Kazakh National Medical University Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2016
NCT03028116
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Kazakh National Medical University, Kazakhstan

Active Ingredients

Drugs in Phase 2 Trials (2)

inactivated influenza vaccine (2 trials)

split virion influenza vaccine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Influenza, Human (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2